New Insights into Acquisition, Boosting, and Longevity of Immunity to Malaria in Pregnant Women
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
BACKGROUND: How antimalarial antibodies are acquired and maintained during pregnancy and boosted after reinfection with Plasmodium falciparum and Plasmodium vivax is unknown. METHODS: A nested case-control study of 467 pregnant women (136 Plasmodium-infected cases and 331 uninfected control subjects) in northwestern Thailand was conducted. Antibody levels to P. falciparum and P. vivax merozoite antigens and the pregnancy-specific PfVAR2CSA antigen were determined at enrollment (median 10 weeks gestation) and throughout pregnancy until delivery. RESULTS: Antibodies to P. falciparum and P. vivax were highly variable over time, and maintenance of high levels of antimalarial antibodies involved highly dynamic responses resulting from intermittent exposure to infection. There was evidence of boosting with each successive infection for P. falciparum responses, suggesting the presence of immunological memory. However, the half-lives of Plasmodium antibody responses were relatively short, compared with measles (457 years), and much shorter for merozoite responses (0.8-7.6 years), compared with PfVAR2CSA responses (36-157 years). The longer half-life of antibodies to PfVAR2CSA suggests that antibodies acquired in one pregnancy may be maintained to protect subsequent pregnancies. CONCLUSIONS: These findings may have important practical implications for predicting the duration of vaccine-induced responses by candidate antigens and supports the development of malaria vaccines to protect pregnant women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. Examples of individuals with relatively stable and dynamic antimalarial responses. Each woman was classified as having dynamic (antibody optical density [OD] standard deviation [SD] ≥ 0.1) or relatively stable responses (antibody OD SD < 0.1). Relatively stable responses to PfAMA1, PfVAR2CSA, and PvAMA1 in the same 10 women (one color is the same woman). Dynamic responses to Plasmodium falciparum antigens PfAMA1, PfVAR2CSA in another 10 women, and dynamic responses to Plasmodium vivax antigens in an additional 10 women (with the exception of the yellow individual who had dynamic responses for all 3 antigens).](https://figures.cochat.ai/paper-figures/2d1ce315342c4dfe9375d6896e98a168/new-insights-into-acquisition-boosting-and-longevity-of-immunity-to-malaria-in-figure-3.jpg)
![Figure 4. Anti–Plasmodium falciparum levels increase with each successive P. falciparum infection. Multivariable linear mixed-effects modeling of the association between antibody levels and number of episodes in species-specific cases (n = 94 and n = 83 for P. falciparum and P. vivax analysis, respectively). The coefficients (95% confidence interval [CI]) for the estimated mean increase in antibody levels per increase in P. falciparum episode number were as follows: PfVAR2CSA 0.03 (0.01–0.05), P = .011; PfAMA1 0.05 (0.02–0.08), P < .001; PfEBA175 0.05 (0.02–0.07) P < .001; PfMSP2 0.02 (0.003–0.04), P = .025; PfMSP3 0.018 (−0.001 to 0.04), P = .063; PvAMA1 − 0.0004 (−0.01 to 0.01), P = .96; measles −0.003 (−0.015 to 0.01), P = .63.](https://figures.cochat.ai/paper-figures/456da6b7b8a5417baf2fdd0a34213cad/new-insights-into-acquisition-boosting-and-longevity-of-immunity-to-malaria-in-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast to the long-term immunity conferred by measles, frequent infections with P.falciparum have been reported to produce relatively short immunologic memory [94].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duration of Humoral Immunity to Common Viral and Vaccine Antigens
Amanna, I. J., Carlson, N. E., & Slifka, M. K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066092 · Cited by 1,286 · cited 2×
“4 to ∞), similar to estimates in vaccinated North Americans [25].”
BackgroundInfluentialAdherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108 · cited 1×
“falciparum that evade existing immunity and accumulate in the placenta [9, 10].”
BackgroundThe burden of malaria in pregnancy in malaria-endemic areas
Steketee, R., Nahlen, B., Parise, M., & Menendez, C. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.28 · Cited by 1,063
Chan, M. (2010) · Cited by 842
Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604
Emerging Infections and Pregnancy
Jamieson, D. J., Theiler, R. N., & Rasmussen, S. A. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1211.060152 · Cited by 588 · cited 1×
“more susceptible to and more severely affected by numerous infectious diseases [1] and has translational implications for the development and use of vaccines to protect pregnant women and their babies.”
BackgroundQuantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490
Immune effector mechanisms in malaria
MARSH, K., & KINYANJUI, S. (2006) · Parasite Immunology · doi:10.1111/j.1365-3024.2006.00808.x · Cited by 419
Effects of Plasmodium vivax malaria in pregnancy.
Nosten, F., McGready, R., Simpson, J., Thwai, K., Balkan, S., Cho, T., Hkirijaroen, L., Looareesuwan, S., & White, N. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09247-2 · Cited by 381 · cited 5×
“modium vivax during pregnancy contributes to maternal anemia, can cause severe illness and death, and leads to low infant birth weight, which is a major risk factor for infant mortality and morbidity [3, 4].”
BackgroundInfluentialSelf-citationFowkes, F. J. I., Richards, J. S., Simpson, J. A., & Beeson, J. G. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000218 · Cited by 345
Self-citationSpecificity of the Protective Antibody Response to Apical Membrane Antigen 1
Hodder, A. N., Crewther, P. E., & Anders, R. F. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.3286-3294.2001 · Cited by 324
Self-citationMalaria during pregnancy in an area of unstable endemicity.
Nosten, F., ter Kuile, F., Maelankirri, L., Decludt, B., & White, N. J. (1991) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(91)90205-d · Cited by 294 · cited 4×
“Fowkes,1,2,4 Rose McGready,6,7,8 Nadia J. Cross,1,4 Mirja Hommel,1,4 Julie A. Simpson,2 Salenna R. Elliott,4 Jack S. Richards,1,3,4 Kurt Lackovic,4 Jacher Viladpai-Nguen,6 David Narum,9 Takafumi Tsuboi,10 Robin F. Anders,5 François Nosten,6,7,8 and James G. Beeson1,4 1Macfarlane Burnet Institute of Medical Research, M…”
BackgroundInfluentialSelf-citationBeeson, J. G., Brown, G. V., Molyneux, M. E., Mhango, C., Dzinjalamala, F., & Rogerson, S. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314899 · Cited by 266
Self-citationStanisic, D. I., Richards, J. S., McCallum, F. J., Michon, P., King, C. L., Schoepflin, S., Gilson, P. R., Murphy, V. J., Anders, R. F., Mueller, I., et al. (2009) · Infection and Immunity · doi:10.1128/iai.01129-08 · Cited by 249
Self-citationWipasa, J., Suphavilai, C., Okell, L. C., Cook, J., Corran, P. H., Thaikla, K., Liewsaree, W., Riley, E. M., & Hafalla, J. C. R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000770 · Cited by 248
Weiss, G. E., Traore, B., Kayentao, K., Ongoiba, A., Doumbo, S., Doumtabe, D., Kone, Y., Dia, S., Guindo, A., Traore, A., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000912 · Cited by 239
Self-citationRoussilhon, C., Oeuvray, C., Müller-Graf, C., Tall, A., Rogier, C., Trape, J.-F., Theisen, M., Balde, A., Pérignon, J.-L., & Druilhe, P. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040320 · Cited by 235
The future for blood‐stage vaccines against malaria
Richards, J. S., & Beeson, J. G. (2009) · Immunology & Cell Biology · doi:10.1038/icb.2009.27 · Cited by 215
Self-citationReed, M. B., Caruana, S. R., Batchelor, A. H., Thompson, J. K., Crabb, B. S., & Cowman, A. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7509 · Cited by 194
Richards, J. S., Stanisic, D. I., Fowkes, F. J. I., Tavul, L., Dabod, E., Thompson, J. K., Kumar, S., Chitnis, C. E., Narum, D. L., Michon, P., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/656413 · Cited by 192
Self-citationKinyanjui, S. M., Conway, D. J., Lanar, D. E., & Marsh, K. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-82 · Cited by 190
Akpogheneta, O. J., Duah, N. O., Tetteh, K. K. A., Dunyo, S., Lanar, D. E., Pinder, M., & Conway, D. J. (2008) · Infection and Immunity · doi:10.1128/iai.01333-07 · Cited by 176
McGREADY, R., DAVISON, B. B., STEPNIEWSKA, K., CHO, T., SHEE, H., BROCKMAN, A., UDOMSANGPETCH, R., LOOAREESUWAN, S., WHITE, N. J., MESHNICK, S. R., et al. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.70.398 · Cited by 170 · cited 1×
“Furthermore, estimates of PfVAR2CSA lasting decades in uninfected women (negative peripheral smear results are always accompanied with placental negative smear results [32]) in this study supports the long-lived nature of these pregnancy-specific responses relative to merozoite antigens.”
Self-citationHost immunity as a determinant of treatment outcome in Plasmodium falciparum malaria
Rogerson, S. J., Wijesinghe, R., & Meshnick, S. R. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70322-6 · Cited by 105
Villegas, L., McGready, R., Htway, M., Paw, M. K., Pimanpanarak, M., Arunjerdja, R., Viladpai‐nguen, S. J., Greenwood, B., White, N. J., & Nosten, F. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01778.x · Cited by 81
Self-citationHviid, L. (2010) · Human Vaccines · doi:10.4161/hv.6.1.9602 · Cited by 75 · cited 1×
“Antibodies against the disease-causing blood stage of malaria have a significant role in protection and target antigens on the surface of merozoites and infected erythrocytes (IE) [6, 7].”
BackgroundBeeson, J. G., Ndungu, F., Persson, K. E. M., Chesson, J. M., Kelly, G. L., Uyoga, S., Hallamore, S. L., Williams, T. N., Reeder, J. C., Brown, G. V., et al. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.22 · Cited by 52
Self-citationAvril, M., Cartwright, M. M., Hathaway, M. J., Hommel, M., Elliott, S. R., Williamson, K., Narum, D. L., Duffy, P. E., Fried, M., Beeson, J. G., et al. (2010) · Infection and Immunity · doi:10.1128/iai.00410-09 · Cited by 39
Self-citationThe case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria
Hviid, L. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.113 · Cited by 34
Zeyrek, F. Y., Palacpac, N., Yuksel, F., Yagi, M., Honjo, K., Fujita, Y., Arisue, N., Takeo, S., Tanabe, K., Horii, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028126 · Cited by 28
Self-citationMemory B cell responses and malaria
Wykes, M., & Good, M. F. (2005) · Parasite Immunology · doi:10.1111/j.1365-3024.2006.00768.x · Cited by 21
Gestational age of the newborn: A clinical manual
Dubowitz, L. M. S., & Dubowitz, V. (1977) · Cited by 18
Cited by
Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria
Beeson, J. G., Drew, D. R., Boyle, M. J., Feng, G., Fowkes, F. J. I., & Richards, J. S. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw001 · Cited by 362
Self-citationRichards, J. S., Arumugam, T. U., Reiling, L., Healer, J., Hodder, A. N., Fowkes, F. J. I., Cross, N., Langer, C., Takeo, S., Uboldi, A. D., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300778 · Cited by 244
“peptide of MSP3 was also included, because it was previously included in multiple cohort studies and has progressed to clinical trials (55).”
BackgroundSelf-citationChallenges and strategies for developing efficacious and long-lasting malaria vaccines
Beeson, J. G., Kurtovic, L., Dobaño, C., Opi, D. H., Chan, J.-A., Feng, G., Good, M. F., Reiling, L., & Boyle, M. J. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau1458 · Cited by 191
Self-citationStanisic, D. I., Fowkes, F. J. I., Koinari, M., Javati, S., Lin, E., Kiniboro, B., Richards, J. S., Robinson, L. J., Schofield, L., Kazura, J. W., et al. (2015) · Infection and Immunity · doi:10.1128/iai.02398-14 · Cited by 151
“The utility of antibodies in serosurveillance is also dependent on the longevity of antibody responses in the absence of infection, which is currently poorly understood and appears to be highly variable among individuals (38, 60).”
BackgroundSelf-citationOpsonising Antibodies to P. falciparum Merozoites Associated with Immunity to Clinical Malaria
Hill, D. L., Eriksson, E. M., Suen, C. S. N. L. W., Chiu, C. Y. H., Ryg-Cornejo, V., Robinson, L. J., Siba, P. M., Müeller, I., Hansen, D. S., & Schofield, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074627 · Cited by 121
Metadata
- Authors
- Fowkes, F. J., McGready, R., Cross, N. J., Hommel, M., Simpson, J. A., Elliott, S. R., Richards, J. S., Lackovic, K., Viladpai-Nguen, J., Narum, D., Tsuboi, T., Anders, R. F., Nosten, F., & Beeson, J. G.
- Affiliations
- Burnet Institute (AU)
- Mahidol University (TH)
- The University of Melbourne (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Shoklo Malaria Research Unit (TH)
- National Institutes of Health (US)
- Ehime University (JP)
- La Trobe University (AU)
- Corresponding author
- Fowkes, Freya JI.
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-09-10
- Volume
- 206
- Issue
- 10
- Pages
- 1612-1621
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC3475637
- OpenAlex
- W2102871981
- Cited by
- 101
- References
- 33
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 14 · 2021: 8 · 2020: 3 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 15 · 2015: 11 · 2014: 12 · 2013: 6 · 2012: 2
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- The Journal of Infectious Diseases (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- Funders
- Wellcome Trust
- University of Oxford
- Medical Research Council
- National Health and Medical Research Council
- Japan Society for the Promotion of Science (23406007)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- malaria in pregnancy, anti-malarial antibodies, Plasmodium falciparum, Plasmodium vivax, merozoite antigens, antibody half-life, immunological memory, reinfection, antibody boosting, vaccine-induced immunity, malaria vaccine development
- MeSH terms
- Adult, Antibodies, Protozoan, Antimalarials, Chloroquine, Female, Humans, Immunoglobulin G, Plasmodium falciparum, Plasmodium vivax, Pregnancy, Thailand, Pregnancy Complications, Parasitic, Case-Control Studies, Malaria, Falciparum, Malaria, Vivax, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.